A newly designed vertebral replacement implant to reconstruct the thoracolumbar spine anteriorly

Dramatic increase in cortical thickness induced by femoral marrow ablation followed by a 3-month treatment with PTH in rats

We previously reported that following mechanical ablation of the marrow from the midshaft of rat femurs, there is a rapid and abundant but transient growth of bone, and this growth is enhanced and maintained over a 3-week period by the bone anabolic hormone parathyroid hormone (PTH). Here, we asked whether further treatment with PTH or bisphosphonates can extend the half-life of the new bone formed in lieu of marrow. We subjected the left femur of rats to mechanical marrow ablation and treated the animals 5 days a week with PTH for 3 weeks (or with vehicle as a control) to replace the marrow by bone. Some rats were euthanized and used as positive controls or treated with vehicle, PTH, or the bisphosphonate alendronate for a further 9 weeks. We subjected both femurs from each rat to soft X-ray, peripheral quantitative computed tomography (pQCT), micro-computed tomography (microCT), dynamic histomorphometry analysis, and biomechanical testing. We also determined the concentrations of serum osteocalcin to confirm the efficacy of PTH. Treatment with PTH for 3 months dramatically enhanced endosteal and periosteal bone formation, leading to a 30% increase in cortical thickness. In contrast, alendronate protected the bone that had formed in the femoral marrow cavity after marrow ablation and 3 weeks of treatment with PTH but failed to promote endosteal bone growth or to improve the biomechanical properties of ablated femurs. We further asked whether calcium-phosphate cements could potentiate the formation of bone after marrow ablation. Marrow cavities from ablated femurs were filled with one of two calcium-phosphate cements, and rats were treated with PTH or PBS for 84 days. Both cements helped to protect the new bone formed after ablation. To some extent, they promoted the formation of bone after ablation, even in the absence of any anabolic hormone. Our data therefore expand the role of PTH in bone engineering and open new avenues of investigation to the field of regenerative medicine and tissue engineering. Local bone marrow aspiration in conjunction with an anabolic agent, a bisphosphonate, or a calcium-phosphate cement might provide a new platform for rapid preferential site-directed bone growth in areas of high bone loss.

The challenge of establishing preclinical models for segmental bone defect research

A considerable number of international research groups as well as commercial entities work on the development of new bone grafting materials, carriers, growth factors and specifically tissue-engineered constructs for bone regeneration. They are strongly interested in evaluating their concepts in highly reproducible large segmental defects in preclinical and large animal models. To allow comparison between different studies and their outcomes, it is essential that animal models, fixation devices, surgical procedures and methods of taking measurements are well standardized to produce reliable data pools and act as a base for further directions to orthopaedic and tissue engineering developments, specifically translation into the clinic. In this leading opinion paper, we aim to review and critically discuss the different large animal bone defect models reported in the literature. We conclude that most publications provide only rudimentary information on how to establish relevant preclinical segmental bone defects in large animals. Hence, we express our opinion on methodologies to establish preclinical critically sized, segmental bone defect models used in past research with reference to surgical techniques, fixation methods and postoperative management focusing on tibial fracture and segmental defect models.

Impacted bone and calcium phosphate cement for repair of femoral head defects: a pilot study

Bone impaction grafting has been advocated for reconstruction of femoral head osteonecrosis. However, bone grafts do not prevent the progression of collapse and subsequent disabling osteoarthritis in late-stage osteonecrosis. We hypothesized reconstruction of large subchondral defects with a mix of impacted morsellized cancellous bone grafts and calcium phosphate cement would afford mechanical stability allowing remodeling into new bone without femoral head collapse. In a pilot study we created a critically sized subchondral defect model in 15 goats following the trapdoor procedure. Defects were left empty (n = 3), filled with morsellized cancellous bone grafts (n = 6), or filled with a mixture of morsellized cancellous bone and calcium phosphate cement (n = 6). No defects collapsed by sacrifice at 12 weeks. Defects filled with morsellized cancellous bone showed complete incorporation and remodeling to a normal trabecular structure. In the morsellized cancellous bone/calcium phosphate cement group, most of the calcium phosphate cement was resorbed in 12 weeks and the mixture was largely replaced by fibrous or fatty marrow. Although the specific mixture did not confirm our hypothesis, we suspect a slower resorbing calcium phosphate cement remains a promising material to mix with morsellized cancellous bone to treat late stages of femoral head osteonecrosis.